https://www.selleckchem.com/products/gs-9973.html
Background Hyperkalemia, defined as a serum potassium level 5 mEq/L that results from multiple mechanisms, is a serious medical condition that can lead to life-threatening arrhythmias and sudden cardiac death. The coexistence of cardiac and renal diseases (ie, cardiorenal syndrome) significantly increases the complexity of care, but its economic impact is not well-characterized in this understudied Medicaid managed care population with hyperkalemia. Objective To calculate the economic impact of hyperkalemia on patients with cardiore
إعجاب
علق
شارك
